Sign In
Buy WINT
$0.0140
+0.0004 (+2.94%)
At Close: Jun 03, 2026
WARRINGTON, PA / ACCESSWIRE / December 19, 2023 / Windtree Therapeutics, Inc. (NASDAQ:WINT) has recently enrolled the first subject in its phase 2 SEISMiC Extension Study to evaluate istaroxime in the
SEISMiC Extension Study results are anticipated in mid-2024 and expected to provide dose optimization for Phase 3
Windtree Therapeutics Announces Issuance of New Pure SERCA2a Activator Patent
08:00am, Thursday, 16'th Nov 2023
This class of SERCA2a Activators selectively activates SERCA2a and may lead to novel therapies for heart failure beyond the Company's current lead program This class of SERCA2a Activators selectively
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
04:15pm, Thursday, 09'th Nov 2023
WARRINGTON, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interven
Windtree to Present at the Sidoti Micro Cap Conference on November 16th
08:00am, Wednesday, 08'th Nov 2023
WARRINGTON, Pa., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage intervent
Windtree to Present at the ThinkEquity Conference on October 19th in New York City
07:30am, Thursday, 12'th Oct 2023
WARRINGTON, Pa., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage intervent
Windtree to Participate in the Lytham Partners Fall 2023 Investor Conference on October 17th
07:30am, Tuesday, 10'th Oct 2023
WARRINGTON, Pa., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage intervent
Windtree to Present at the Dawson James Small Cap Growth Conference on October 12th
08:00am, Tuesday, 03'rd Oct 2023
WARRINGTON, Pa., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage intervent
7 F-Rated Biotech Stocks You Shouldn't Touch With a 10-Foot Pole
07:20am, Friday, 25'th Aug 2023
Investing in biotech stocks can be challenging. The rewards can be great when your company hits on a popular drug, treatment or product.
3 Penny Stocks To Watch Before Next Week; Time To Buy?
04:35pm, Monday, 05'th Jun 2023
Penny stocks often represent an intriguing opportunity for investors. Defined by the U.S. Securities and Exchange Commission as shares trading for less than $5, these stocks generally belong to small
Why Is Windtree Therapeutics (WINT) Stock Down 58% Today?
09:24am, Thursday, 20'th Apr 2023
Windtree Therapeutics (NASDAQ: WINT ) stock is falling on Thursday after the company announced the departure of its Chairman of the Board of Directors. James Huang is departing from Windtree Therapeut
Why Is Windtree Therapeutics (WINT) Stock Up 190% Today?
01:20pm, Monday, 17'th Apr 2023
On an otherwise bearish day in the markets, many investors may be looking for some good news. For those on such a search, taking a look at some of the big movers in the biotech sector is a great place
Windtree Therapeutics, Inc. (WINT) Upgraded to Buy: Here's Why
01:41pm, Friday, 18'th Nov 2022
Windtree Therapeutics, Inc. (WINT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
What The Stock Market Did Today & Top Penny Stocks To Watch Now
09:50pm, Wednesday, 28'th Sep 2022
Hot penny stocks to watch & what happened in the stock market today. The post What The Stock Market Did Today & Top Penny Stocks To Watch Now appeared first on Penny Stocks to Buy, Picks, News and Inf
Windtree to Present at the Ladenburg Thalmann Healthcare Conference
04:05pm, Wednesday, 21'st Sep 2022
WARRINGTON, Pa., Sept. 21, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascula
